evipedia.ai
← Back

Licorice Root for Health & Longevity

Evidence Review created on 08/27/2026 using AI4L / Opus 5

Also known as: Licorice, Liquorice, Glycyrrhiza glabra, Glycyrrhiza uralensis, Glycyrrhiza inflata, Gan Cao, Yashtimadhu, Mulethi, Sweet Root, Deglycyrrhizinated Licorice, DGL, Glycyrrhizin, Glycyrrhizic Acid

Motivation

Licorice root is the sweet-tasting root of Glycyrrhiza glabra and its close relatives, legume shrubs grown across the Mediterranean, the Middle East, and Asia. Its signature compound, glycyrrhizin, is many times sweeter than sugar and also changes how the body handles the stress hormone cortisol. That dual character makes licorice unusual: it is at once a flavouring, a traditional remedy, and a substance able to move blood pressure and mineral balance.

Licorice has been used for thousands of years in Egyptian, Greek, Chinese, and Ayurvedic practice, mostly for coughs, sore throats, and stomach complaints. It remains one of the most widely consumed medicinal plants in the world, appearing in teas, candies, herbal formulas, and processed extracts from which the sweet compound has been stripped. Several national health agencies now set limits on how much of it people should take in.

This review examines what controlled human research shows about licorice root: where its effects are measurable, how large they are, at what intakes problems begin, and how the available preparations differ in both promise and hazard.

Benefits - Risks - Protocol - Conclusion

A short, curated set of high-level overviews of licorice root from longevity-focused platforms and the peer-reviewed literature.

Three priority experts are absent from this list. Repeated web and on-site searches of foundmyfitness.com and peterattiamd.com returned no article, episode, or transcript in which Rhonda Patrick or Peter Attia discusses licorice root in a health context. Chris Kresser’s site covers licorice only as one entry among many inside broader pieces — a numbered section on antiviral use within a cold-and-flu remedy round-up, and brief mentions in adrenal and digestive articles — with no piece devoted to it, so nothing there met the depth bar used here.

Grokipedia

Liquorice

The primary encyclopedia entry for the root and rhizome of Glycyrrhiza glabra, covering botany, cultivation, chemistry, traditional and modern uses, and the regulatory limits placed on glycyrrhizin intake.

Examine

Licorice

An evidence-graded monograph with 194 references, covering dosing across preparations, a safety database with drug interactions and pregnancy guidance, and outcome grades for blood pressure, testosterone, and sore throat.

ConsumerLab

Licorice and DGL Supplements, Candies, and Tea Review

Independent laboratory testing of 11 licorice and deglycyrrhizinated products for glycyrrhizic acid content and heavy metals, with three deglycyrrhizinated products not approved for carrying more of the compound than expected.

Systematic Reviews

The pooled clinical literature on licorice root, spanning both its claimed benefits and its principal cardiovascular risk.

Mechanism of Action

Licorice root works through two chemically separate families of compounds, and almost every practical question about it turns on which family a product contains.

The first is glycyrrhizin (also called glycyrrhizic acid), a soap-like plant compound (saponin) at roughly 2–8% of the dried root. It is poorly absorbed intact. Gut bacteria hydrolyse it to glycyrrhetinic acid, which is absorbed, conjugated in the liver, excreted in bile and recycled through the gut — an enterohepatic loop giving a terminal half-life of roughly 10–30 hours and letting the compound accumulate with daily use. Glycyrrhetinic acid potently inhibits 11β-HSD2 (11-beta-hydroxysteroid dehydrogenase type 2, the kidney enzyme that converts active cortisol into inactive cortisone). With that enzyme blocked, cortisol switches on the mineralocorticoid receptor, the same receptor aldosterone uses. Sodium and water are retained, potassium is excreted, blood pressure rises, and the body’s own renin (the kidney enzyme that switches on salt-retaining signalling) and aldosterone are suppressed. Because the enzyme must be resynthesised, the effect persists one to two weeks after stopping.

A competing account holds that glycyrrhetinic acid also binds the mineralocorticoid receptor directly rather than acting only through enzyme inhibition; both are supported and not mutually exclusive. Glycyrrhizin additionally binds HMGB1 (a protein released by injured cells that amplifies inflammation), the leading explanation for its liver effects.

The second family is the flavonoids — glabridin, liquiritigenin, isoliquiritigenin, licochalcone A — which are antioxidant, dampen NF-κB (a master switch for inflammatory gene expression), weakly engage estrogen receptors, and carry no mineralocorticoid activity.

Historical Context & Evolution

Licorice root was buried with Egyptian pharaohs, described by Theophrastus in the fourth century BCE for cough and thirst, and remains the single most frequently prescribed herb in Chinese medicine as Gan Cao, where its traditional role is to “harmonise” other ingredients rather than to act alone.

Its modern medical career began in 1946, when the Dutch pharmacist Revers reported that peptic-ulcer patients taking a licorice paste felt relief; endoscopic follow-up suggested genuine ulcer healing. He also documented the price: marked facial and limb swelling in many of those treated. That drove two decades of chemistry. Isolating glycyrrhetinic acid and esterifying it produced carbenoxolone, licensed in the United Kingdom in the 1960s as a gastric-ulcer drug. It worked, and was displaced not because it failed but because acid-blocking drugs healed as well without the mineralocorticoid burden.

The swelling became the more durable legacy. Cases of licorice-induced pseudoaldosteronism (high blood pressure and low potassium with suppressed aldosterone) accumulated through the 1960s and 1970s without a mechanism. The explanation arrived in 1988, when work localising 11β-HSD2 identified it as the tissue-specific protector of the mineralocorticoid receptor that licorice was disabling. Licorice thereby became the tool compound through which the syndrome of apparent mineralocorticoid excess (cortisol acting where aldosterone normally would) was defined.

Two commercial responses followed and are still evolving: deglycyrrhizinated licorice, which strips the offending saponin, and standardised flavonoid extracts concentrating glabridin instead. Whether either retains the original benefit is a question the trials are still answering.

Expected Benefits

High 🟩 🟩 🟩

Relief of Functional Dyspepsia and Reflux Symptoms

A flavonoid-rich, deglycyrrhizinated extract reduced the symptoms of functional dyspepsia (persistent indigestion with no structural cause) and of reflux in two placebo-controlled trials. The proposed mechanism is mucosal protection plus anti-inflammatory flavonoid action rather than acid suppression. Evidence comes from a 30-day trial in 50 adults with functional dyspepsia and a 28-day trial in 200 adults with reflux, both using validated symptom scales. Both were sponsored by the extract’s manufacturer, a direct commercial interest not yet offset by independent replication.

Magnitude: Total dyspepsia symptom scores separated from placebo by day 15 and day 30; in the reflux trial heartburn separated by day 14 and quality-of-life scores improved by day 28. The literature reports no standardised effect size for either outcome.

Prevention of Postoperative Sore Throat

Gargling or sucking a licorice preparation before general anaesthesia lowered the incidence and severity of throat pain after the breathing tube was removed. The proposed mechanism is topical anti-inflammatory action on irritated mucosa. The evidence is a meta-analysis of five randomised controlled trials in 609 adults, with trial sequential analysis confirming the sample was adequate. No significant adverse events were reported.

Magnitude: Risk ratio (the chance of the outcome on treatment divided by the chance without it) 0.44, 95% confidence interval (the range within which the true value most likely falls) 0.28–0.69, for sore throat 24 hours after surgery — roughly a 56% relative reduction — with a standardised mean difference (effect size in standard-deviation units) of −0.69 for severity.

Improved Liver Enzymes and Liver Fat

Licorice preparations lowered circulating liver enzymes in people with established liver disease, with purified glycyrrhizic acid products performing best. The proposed mechanism is HMGB1 binding and reduced oxidative stress. Evidence spans a meta-analysis of 15 randomised trials in 1,367 patients and a 12-week trial of 1,000 mg licorice root daily in 60 women with fatty liver disease. These populations already have liver injury, so the size of any effect in a healthy person is unknown.

Magnitude: Alanine aminotransferase (a liver enzyme released when liver cells are damaged) fell 15.63 units per litre (95% confidence interval −25.08 to −6.18) and aspartate aminotransferase (a second enzyme that leaks from injured liver cells) 7.37 units per litre; ultrasound-graded liver fat and insulin resistance also improved in the fatty-liver trial.

Faster Healing of Recurrent Mouth Ulcers

Licorice pastes, patches, and mouthwashes shortened healing time and reduced pain in recurrent aphthous stomatitis (repeated painful mouth ulcers). Proposed mechanisms include anti-inflammatory, antioxidant, and antibacterial effects plus a raised growth factor that maintains the lining of the mouth. The evidence is a systematic review of six randomised trials in 314 people; the reviewers judged the trials too heterogeneous to pool. No adverse effects were recorded in any intervention group.

Magnitude: Healing was typically complete within 4–8 days using 1% or 5% topical preparations, with consistent reductions in pain and ulcer size across trials. The literature gives no pooled effect size because heterogeneity precluded meta-analysis.

Higher Response Rates in Alopecia Areata and Vitiligo

Compound glycyrrhizin, a licorice-derived tablet and injection combining glycyrrhizin with two amino acids, raised response rates in alopecia areata (patchy autoimmune hair loss) and vitiligo (patchy loss of skin pigment) when added to conventional treatment. The proposed mechanism is glycyrrhizin’s suppression of inflammatory signalling rather than any flavonoid effect. Evidence is a meta-analysis of 23 randomised trials in alopecia areata and a meta-analysis of 17 randomised trials in vitiligo. Both pool small unblinded Chinese add-on trials and come from one author group.

Magnitude: Cure rate rose with a risk ratio of 1.60 (95% confidence interval 1.47–1.74) across 23 trials in 2,219 patients with alopecia areata and 1.62 (1.32–1.99) across 17 trials in 1,492 patients with vitiligo. Fluid-retention swelling was about 2.5 times more common on compound glycyrrhizin (risk ratio 2.53, 95% confidence interval 1.04–6.19).

Medium 🟩 🟩

Higher Helicobacter pylori Eradication as an Add-On

Adding licorice to standard clarithromycin-based triple therapy raised eradication rates in a randomised trial of 120 adults with dyspepsia. The proposed mechanism is direct antibacterial flavonoid activity plus inhibition of bacterial adhesion to the gastric lining. A separate placebo-controlled trial of a deglycyrrhizinated extract in 107 infected adults reduced bacterial load without antibiotics. Both were single-centre, and the second was manufacturer-funded.

Magnitude: Eradication reached 83.3% with added licorice versus 62.5% with triple therapy alone, an absolute gain of about 21 percentage points. Used alone, 150 mg of extract daily for 60 days turned the stool antigen test negative in 56% versus 4% on placebo.

Modest Reduction in Body Weight and Body Fat ⚠️ Conflicted

Pooled clinical data show small reductions in weight and body mass index after licorice intake, attributed to flavonoid-driven increases in fat oxidation. A meta-analysis of 26 trials in 985 participants found statistically significant but very small effects, while an 8-week trial of licorice flavonoid oil in overweight adults and athletic men found nothing. Net reading: the pooled effect is real in direction but far too small to matter on its own.

Magnitude: Weighted mean difference (the pooled average change across trials) −0.433 kg for body weight (95% confidence interval −0.683 to −0.183) and −0.150 kg/m² for body mass index. A trial pairing 1.5 g licorice extract daily with a low-calorie diet reported larger changes in weight, body fat, and insulin resistance than diet alone.

Relief of Menopausal Hot Flashes

Licorice reduced the number and duration of hot flashes in postmenopausal women, plausibly through weak estrogen-like activity of the flavonoids glabridin and glabrene. The evidence is a 90-day randomised trial in 60 women comparing 1,140 mg licorice daily with hormone therapy, with no placebo arm. Hormone therapy reduced severity more; licorice performed comparably on frequency and better on duration.

Magnitude: Directionally, hot-flash frequency and duration fell at 1,140 mg daily and were not significantly different from hormone therapy, while severity improved less than with hormones. The literature reports no between-group effect size for these outcomes.

Lowered Androgen Levels in Women with Androgen Excess

In women, licorice lowers circulating testosterone, which is the desired direction in hirsutism (excess coarse body hair in women) and polycystic ovary syndrome (irregular cycles with excess male hormones). The proposed mechanism is inhibition of 17β-hydroxysteroid dehydrogenase and 17,20-lyase (two enzymes in testosterone synthesis). Evidence is a small open study in nine healthy women and a comparative trial adding licorice to spironolactone in 32 women.

Magnitude: Total testosterone fell from 27.8 ± 8.2 to 17.5 ± 6.4 ng/dL over two menstrual cycles on 3.5 g licorice daily, returning to baseline after withdrawal. Added to spironolactone, licorice also prevented the volume depletion that affected 20% on spironolactone alone.

Reduced Severity of Atopic Dermatitis with Topical Use

Topical licorice extract reduced the redness, swelling, and itching of atopic dermatitis (an itchy, relapsing inflammatory skin condition). The proposed mechanism is flavonoid suppression of inflammatory signalling in the skin rather than steroid activity. The evidence is a double-blind trial of 1% and 2% licorice gel against a base gel, 30 patients per group, run over two weeks. It is a single small trial with no comparison against topical steroids.

Magnitude: Directionally, the 2% gel outperformed both the 1% gel and the base gel on redness, swelling and itching scores over two weeks, each difference reaching statistical significance. The literature reports no standardised effect size for this outcome.

Reduced Dental Plaque and Gum Inflammation

Licorice mouthwash and locally applied licorice gel lowered dental plaque and gum inflammation scores and suppressed the bacteria behind dental caries (tooth decay) and periodontal disease (destructive gum disease). The proposed mechanism is direct antibacterial flavonoid action against Streptococcus mutans and periodontal pathogens. Evidence comes from a 5-day randomised trial of Glycyrrhiza uralensis mouthwash in 60 adults and a split-mouth trial of licorice gel against tetracycline gel in 20 diabetic patients. They test different preparations against different comparators, so neither finding is independently replicated.

Magnitude: Directionally, plaque and gum-inflammation scores fell after five days of daily rinsing, and pocket depth and gum attachment improved more with licorice gel than with tetracycline gel at one month. The published reports give no effect size for either outcome.

Improved Blood Lipids and Resistance to LDL Oxidation

Licorice shifted the circulating lipid panel and made low-density lipoprotein (LDL, the cholesterol particle that drives artery plaque) harder to oxidise. The proposed mechanism is antioxidant flavonoid action, chiefly glabridin, rather than any effect on cholesterol synthesis. Evidence is a 6-month randomised trial of licorice-root extract in healthy adults and an 8-week trial pairing 1.5 g licorice extract daily with a low-calorie diet in 66 women. Both are single small trials in narrow populations.

Magnitude: Plasma LDL oxidation fell about 20% over six months of licorice-root extract. In the second trial triglycerides, total cholesterol, LDL and HDL (high-density lipoprotein, the particle that carries cholesterol away from the artery wall) cholesterol all separated from a diet-only control, though the published report gives no between-group figure for any of them.

Low 🟩

Skin Brightening and Reduced Hyperpigmentation

Topical glabridin and licorice extracts inhibit tyrosinase (the enzyme that manufactures skin pigment) and are widely used cosmetic actives. Human evidence remains small and largely uncontrolled, as summarised in a review of glabridin’s biological effects.

Magnitude: Not quantified in available studies. No controlled trial has measured pigment change against placebo using a validated scale; the published human reports are small uncontrolled cosmetic series.

Support for Fatigue and Cortisol Availability

Because licorice blocks the enzyme that inactivates cortisol, it prolongs cortisol’s action and is widely used for low-energy states. The human data are physiological rather than outcome-based; a clinical review confirms corticosteroid-like activity but identifies no controlled fatigue trials.

Magnitude: Not quantified in available studies. No controlled trial has measured fatigue, energy, or exercise capacity as an endpoint; the evidence stops at demonstrated inhibition of cortisol breakdown.

Respiratory and Antiviral Support ⚠️ Conflicted

Licorice’s oldest use is for coughs and respiratory infection, attributed to glycyrrhizin’s antiviral and anti-inflammatory action. Two randomised trials disagree: one in 60 moderately ill COVID-19 patients changed no symptom, while one in 52 critically ill patients shortened intensive-care stay. Net reading: the traditional claim remains unconfirmed.

Magnitude: Directionally neutral for symptoms, oxygenation and mortality, with the single positive signal a shorter intensive-care stay in critical illness. The published reports give no effect size for either outcome.

Speculative 🟨

Reduction of Cellular Senescence

Licochalcone A, a licorice flavonoid, reversed markers of cell ageing in aged human fat-derived stem cells, as reported in longevity coverage. The basis is one cell-culture experiment, with no animal or human data.

Lifespan Extension in Model Organisms

Licorice extract raised survival of Caenorhabditis elegans under oxidative stress and extended its lifespan by 14.28%. The basis is invertebrate and antioxidant-assay work only, with no mammalian or human data.

Benefit-Modifying Factors

  • 11β-HSD2 gene variants: Reduced-function HSD11B2 variants leave less enzyme for glycyrrhetinic acid to block, so carriers reach the cortisol-extending effect at lower intakes, though the usable window before pressure and potassium shift narrows correspondingly.

  • Gut microbiome composition: Glycyrrhizin is inert until gut bacteria convert it to glycyrrhetinic acid using β-glucuronidase (the bacterial enzyme that performs that step). Recent broad-spectrum antibiotics reduce conversion and weaken the effect of whole-root preparations.

  • Baseline cortisol and blood pressure: Those starting with low-normal blood pressure and blunted morning cortisol tend to notice the energy and pressure effects most; anyone already at the top of the normal range gains little benefit before hitting the risk ceiling.

  • Sex: The androgen-lowering effect is a benefit in women with excess male hormones and an unwanted effect in men. The hot-flash benefit likewise applies only to women, and has no male counterpart.

  • Pre-existing gastrointestinal disease: Benefit is concentrated in people who actually have reflux, functional indigestion, or Helicobacter pylori infection. In asymptomatic users the gastrointestinal trials predict essentially nothing.

  • Age: Adults past midlife show greater sensitivity to 11β-HSD2 inhibition and reach a given blood-pressure change at lower intake, so the usable dose window that still delivers benefit narrows with each decade.

  • Preparation and glycyrrhizin content: Deglycyrrhizinated and flavonoid-standardised extracts retain the gastrointestinal and metabolic benefits but forfeit the cortisol-extending effect entirely; whole root delivers both.

Potential Risks & Side Effects

High 🟥 🟥 🟥

Elevated Blood Pressure

Glycyrrhetinic acid blocks 11β-HSD2 in the kidney, letting cortisol activate mineralocorticoid receptors and driving sodium retention. Blood pressure rises in proportion to intake. A meta-analysis of 18 studies in 337 people and a randomised crossover trial at only 100 mg glycyrrhizic acid daily both found significant increases. Reversal takes one to several weeks after stopping, and people with existing cardiovascular disease are most exposed.

Magnitude: Pooled systolic rise 5.45 mmHg (95% confidence interval 3.51–7.39) and diastolic 3.19 mmHg. At 100 mg glycyrrhizic acid daily, home systolic pressure rose 3.1 mmHg over two weeks. Daily dose tracked systolic and diastolic change closely (r², the share of variation explained, of 0.55 and 0.65).

Hypokalemia

The same mineralocorticoid effect drives urinary potassium loss, producing hypokalemia (low blood potassium), which causes weakness, cramps, and heart-rhythm disturbance. The meta-analysis of chronic ingestion quantifies the average shift, while a published hypertensive emergency from licorice tea shows the tail of the distribution. Severity ranges from an asymptomatic laboratory change to life-threatening depletion; risk climbs with diuretics, laxatives, and low dietary potassium.

Magnitude: Mean plasma potassium fell 0.33 mmol/L (95% confidence interval −0.42 to −0.23) across trials, with plasma renin activity down 0.82 ng/mL/hour and aldosterone down 173 pmol/L. Case reports describe values as low as 1.5 mmol/L when licorice is combined with a diuretic.

Fluid Retention and Edema

Sodium and water retention produce puffiness of the face, hands, and ankles plus weight gain, often before any measurable pressure change. The toxicological review of Glycyrrhiza glabra lists edema among the most consistent effects and identifies old age, female sex, prolonged gut transit, and anorexia nervosa as amplifiers. It resolves after withdrawal but can decompensate existing heart failure.

Magnitude: Directionally, swelling appears within one to four weeks and becomes common above roughly 400 mg glycyrrhizin daily, with occasional reports from 100 mg daily. The literature reports no pooled incidence figure for edema.

Medium 🟥 🟥

Harm to the Developing Offspring After Use in Pregnancy

Glycyrrhizin inhibits the placental enzyme that shields the fetus from maternal cortisol. In a Finnish birth cohort followed to age 12, children of mothers with high licorice intake scored lower on cognitive testing, and girls showed earlier puberty. The evidence is prospective observational data in 378 children, consistent across several reports from the same cohort but not independently replicated. Every major reference source now advises avoidance in pregnancy.

Magnitude: Children exposed to 500 mg or more of glycyrrhizin weekly scored 7 intelligence-quotient points lower (95% confidence interval 3.1–11.2) and had 3.3-fold higher odds (95% confidence interval 1.4–7.7) of attention-deficit/hyperactivity problems than those exposed to 249 mg or less weekly.

Low 🟥

Cardiac Arrhythmia and Cardiac Events

Potassium depletion can trigger irregular heart rhythms. The US Food and Drug Administration has warned that about 57 g (2 ounces) of black licorice daily for two weeks may do so in adults over 40. The supporting evidence is case reports, catalogued in the toxicological review.

Magnitude: Not quantified in available studies. Only case reports and a regulatory advisory exist; no controlled trial has measured arrhythmia incidence against a comparator.

Hypokalemic Myopathy and Rhabdomyolysis

Severe potassium loss can injure muscle, producing weakness, pain, and rhabdomyolysis (muscle breakdown that can damage the kidneys). A case report describes potassium of 1.5 mmol/L and creatine kinase (a marker of muscle damage) of 18,400 units per litre in a man also taking a diuretic.

Magnitude: Not quantified in available studies. Only isolated case reports exist; no trial has measured creatine kinase or muscle injury as an endpoint during licorice exposure.

Reduced Serum Testosterone in Men ⚠️ Conflicted

One Italian group reports falls in male testosterone through inhibition of testosterone-synthesising enzymes, in a 1999 report and a 2003 replication; an independent group measuring salivary testosterone found no change. Net reading: a real but modest effect at high intake, unreliable at ordinary doses.

Magnitude: Directionally downward, with a mean 26% fall after one week at roughly 7 g licorice daily, reversing on withdrawal. Given the contradictory salivary data and absence of controlled replication, the literature reports no pooled effect size.

Unpredictable Herb–Drug Interactions ⚠️ Conflicted

Laboratory work suggests licorice inhibits several drug-metabolising enzymes, but a phase 1 study in 14 women found no clinically relevant change in CYP3A4/5, CYP2C9, CYP2D6, or CYP1A2 (liver enzymes that clear most medicines). Net reading: the metabolic interaction is largely theoretical; the pharmacodynamic one, with potassium-lowering drugs, is not.

Magnitude: Directionally neutral for drug metabolism — no significant change in exposure to four probe drugs after two weeks of a standardised extract — while the potassium-depleting interaction with diuretics is documented in case reports. The literature gives no effect-size figure for either.

Speculative 🟨

Estrogen-Receptor Activity in Hormone-Sensitive Tissue

Glabridin and glabrene engage estrogen receptors in cell and rodent vascular experiments, raising a theoretical concern for hormone-sensitive cancers. No human outcome data exist in either direction.

Risk-Modifying Factors

  • 11β-HSD2 gene variants: Partial loss-of-function variants in the HSD11B2 gene leave less enzyme reserve, so carriers reach hypokalemia and hypertension at intakes others tolerate. This is the same gene mutated in congenital apparent mineralocorticoid excess.

  • Baseline potassium, renin, and aldosterone: Starting potassium below 4.0 mmol/L, or already-suppressed renin, marks someone whose margin is thin. Low-renin hypertension in particular is often the first clue that licorice is the culprit.

  • Sex: Women show mineralocorticoid effects at lower intakes than men and are over-represented in the case literature. Men face the androgen-lowering effect that women may find useful.

  • Pre-existing conditions: Hypertension, heart failure, chronic kidney disease, cirrhosis with ascites, primary aldosteronism, and eating disorders with purging all amplify the sodium-retention and potassium-loss effects sharply.

  • Age: Enzyme activity and renal potassium handling both decline with age. Adults past 60 develop hypertension and arrhythmia at intakes younger adults tolerate, which is why the Food and Drug Administration advisory is age-specific.

  • Concurrent medications: Thiazide and loop diuretics, stimulant laxatives, corticosteroids, and digoxin each compound either potassium loss or its consequences.

Key Interactions & Contraindications

  • Thiazide and loop diuretics (hydrochlorothiazide, indapamide, furosemide): Caution bordering on avoidance — additive potassium loss has produced potassium of 1.5 mmol/L and rhabdomyolysis. Monitoring protocols check potassium within two weeks of starting; otherwise the pair is left uncombined.

  • Corticosteroids (prednisone, hydrocortisone, topical or inhaled steroids): Caution. Licorice blocks cortisol inactivation, raising effective steroid exposure and the risk of hypertension, edema, and glucose elevation. The usual response is a lower steroid dose or separated use.

  • Digoxin: Absolute contraindication in practice. Licorice-induced hypokalemia sharply increases digoxin toxicity, which presents as arrhythmia and visual disturbance. No safe monitoring interval offsets this.

  • Blood-pressure drugs of every class (ACE inhibitors, angiotensin receptor blockers, calcium-channel blockers — all of which relax vessels or shed fluid): Caution. Licorice directly opposes them, causing loss of blood-pressure control. Where the pairing is unavoidable, a deglycyrrhizinated preparation is the usual substitute.

  • Spironolactone and eplerenone (mineralocorticoid receptor blockers): Monitor. These oppose licorice at the receptor, so effects partly cancel; deliberately exploited in polycystic ovary syndrome to blunt spironolactone’s volume depletion.

  • Warfarin: Monitor. Licorice may accelerate warfarin clearance, reducing anticoagulant effect and raising clot risk. The international normalised ratio (a standardised measure of clotting time) is checked weekly for a month after any change.

  • Stimulant laxatives (senna, bisacodyl) and over-the-counter potassium-wasting products: Caution. Combined gastrointestinal and renal potassium loss produces weakness and arrhythmia faster than either alone. Separated use and added potassium-rich foods blunt it.

  • Over-the-counter non-steroidal anti-inflammatory drugs (ibuprofen, naproxen): Caution. Both promote sodium and fluid retention, compounding edema and blood-pressure elevation. Concurrent use is usually limited to short courses.

  • Supplements with additive potassium-lowering or pressure-raising effects: Caution with high-dose caffeine, yohimbine, bitter orange (synephrine), and dandelion or juniper used as diuretics. Each pushes the same direction as licorice.

  • Supplements with additive mineralocorticoid or steroid effects: Caution with high-dose DHEA (dehydroepiandrosterone, an adrenal hormone precursor) and adrenal glandular products, which raise the same steroid burden licorice prolongs.

Populations who should avoid Licorice Root:

  • Pregnancy at any stage, and breastfeeding — glycyrrhizin crosses the placenta and enters breast milk
  • Uncontrolled hypertension (systolic above 140 mmHg or diastolic above 90 mmHg on treatment)
  • Heart failure of New York Heart Association Class II or worse
  • Chronic kidney disease stage 3 or beyond (estimated glomerular filtration rate below 60 mL/min/1.73 m², a measure of kidney filtering capacity)
  • Cirrhosis with ascites (fluid build-up in the abdomen), or Child-Pugh Class B or C liver disease
  • Baseline serum potassium below 3.5 mmol/L from any cause
  • Primary aldosteronism, Liddle syndrome, or apparent mineralocorticoid excess (inherited or acquired conditions that already drive salt retention and potassium loss)
  • Hormone-sensitive cancers of the breast, uterus, or prostate, pending human safety data
  • Men actively treating low testosterone

Risk Mitigation Strategies

  • Daily glycyrrhizin ceiling of 100 mg: The European and World Health Organization ceiling. Above it, blood-pressure rise and potassium loss become predictable rather than idiosyncratic.

  • Deglycyrrhizinated or flavonoid-standardised extracts for gastrointestinal use: These retain the digestive benefit while removing the mineralocorticoid mechanism that drives hypertension, hypokalemia, and edema entirely.

  • Serum potassium and blood pressure at baseline and at 2–4 weeks: Catches the drift toward hypokalemia and hypertension before symptoms appear, when simple withdrawal fully reverses it.

  • Cycling of whole-root preparations, 4–6 weeks on and 2 weeks off: The two-week break allows 11β-HSD2 resynthesis, preventing the cumulative enzyme blockade that produces edema and pressure elevation with continuous use.

  • Dietary potassium raised to 3,500–4,700 mg daily: Leafy greens, avocado, and legumes offset urinary potassium loss, reducing the muscle weakness, cramps, and arrhythmia risk that follow depletion.

  • Sodium restriction below 2,300 mg daily during whole-root use: Licorice retains whatever sodium is present, so lowering intake blunts fluid retention and the resulting blood-pressure rise.

  • Weekly morning body-weight tracking: A gain of 1–2 kg without diet change signals fluid retention early, before visible facial or ankle swelling develops.

  • Withdrawal 2 weeks before elective surgery: Allows potassium, renin, and aldosterone to normalise, avoiding intraoperative arrhythmia and unpredictable interaction with anaesthetic agents.

Therapeutic Protocol

  • Whole licorice root, conventional herbal dose: 1–5 g dried root daily as tea or capsules, delivering roughly 30–150 mg glycyrrhizin depending on species and origin. Practitioners rarely exceed 4–6 continuous weeks.

  • Deglycyrrhizinated licorice for digestive use: 380–760 mg chewed 20 minutes before each of two or three meals. The chewable form matters — saliva mixing is thought to be part of the mucosal effect.

  • Flavonoid-standardised deglycyrrhizinated extract: 75 mg twice daily, or 150 mg once daily, the doses used in the manufacturer-run dyspepsia, reflux, and Helicobacter pylori trials.

  • Licorice flavonoid oil for metabolic use: 300 mg daily, the dose used in the body-composition trials. It carries no glycyrrhizin and therefore none of the mineralocorticoid ceiling.

  • Integrative versus conventional framing: Functional-medicine practice uses whole root for cortisol support; conventional gastroenterology, where it appears at all, uses deglycyrrhizinated forms. Neither approach is the default here.

  • Attribution of approaches: The peptic-ulcer protocol descends from Revers’s 1946 Dutch work and its carbenoxolone successor; the cortisol-extension protocol traces to William Jefferies’s adrenal-support writing and its adoption in functional medicine.

  • Best time of day: Morning, with or shortly after breakfast, for whole root — this aligns the cortisol-prolonging effect with the natural morning peak and avoids evening alertness that disrupts sleep.

  • Half-life and dosing frequency: Glycyrrhetinic acid has a terminal half-life around 10–30 hours with enterohepatic recycling; 11β-HSD2 inhibition persists 1–2 weeks. Once-daily dosing is therefore sufficient for whole root.

  • Split dosing for deglycyrrhizinated forms: Split before meals, since the effect is local and mucosal rather than systemic. Single daily dosing wastes most of the exposure window.

  • Genetic considerations: HSD11B2 variants reduce enzyme reserve and call for the lowest effective dose or a deglycyrrhizinated form. NR3C2 mineralocorticoid receptor variants may similarly alter sensitivity.

  • Sex-based dosing: Women reach mineralocorticoid effects at lower intakes, so protocols start them at the bottom of any range. Men seeking cortisol support accept a testosterone trade-off at higher doses.

  • Age-based dosing: Beyond 60, practitioners halve the starting dose and extend the monitoring interval, since renal potassium handling and enzyme reserve both decline with age.

  • Baseline biomarkers that guide dosing: Potassium above 4.2 mmol/L, blood pressure below 120/80 mmHg, and unsuppressed renin define the widest usable window. Anything less argues for a deglycyrrhizinated form.

  • Pre-existing conditions that alter response: Prolonged gastrointestinal transit increases glycyrrhizin conversion and effect; recent antibiotics reduce it. Reflux and functional dyspepsia predict the clearest symptomatic response.

Discontinuation & Cycling

  • Not intended as a lifelong intervention: Whole-root licorice is a short-course agent. Continuous use produces cumulative enzyme blockade, and no trial has run glycyrrhizin-containing preparations safely beyond a few months.

  • Deglycyrrhizinated forms may be used longer: Without glycyrrhizin the mineralocorticoid ceiling disappears, and these preparations are used continuously for reflux, though long-term safety data past a year remain thin.

  • Withdrawal effects are minimal but delayed reversal is not: Stopping produces no rebound syndrome. Blood pressure, potassium, renin, and aldosterone take one to several weeks to normalise as the enzyme is resynthesised.

  • No taper is required: Because there is no dependence or receptor downregulation, abrupt cessation is safe. The exception is anyone on corticosteroids, whose effective steroid exposure will fall when licorice stops.

  • Cycling is standard practice for whole root: Four to six weeks on, two weeks off, timed to allow 11β-HSD2 recovery. This is the main lever that keeps cumulative mineralocorticoid load from building.

  • Tolerance to benefit is not documented: Cycling exists to limit harm, not to preserve efficacy. No study reports diminishing digestive or symptomatic response with continued use.

Sourcing and Quality

  • Glycyrrhizic acid content on the label: Independent testing found licorice root capsules at 23.8–29.7 mg per serving and licorice tea at 46 mg per bag, while most products disclose nothing.

  • Deglycyrrhizinated is not glycyrrhizin-free: Testing found up to 7.6 mg per serving in products labelled deglycyrrhizinated, and three of the tested products failed on that basis.

  • Species identity: Glycyrrhiza glabra, Glycyrrhiza uralensis, and Glycyrrhiza inflata differ in flavonoid profile and interaction potential, and products labelled as one species have been found to contain another.

  • Third-party testing: A certification mark from USP, NSF International, or an equivalent independent laboratory covers identity, glycyrrhizic acid quantification, and heavy metals.

  • Heavy-metal testing on teas: Independent testing of 11 licorice products found heavy-metal levels uniformly low, but root crops concentrate soil metals, and only certification covering lead and cadmium documents the level in a given tea.

  • Standardised extracts for reproducible dosing: Flavonoid-standardised products specify glabridin at 3.5% or more and cap glycyrrhizin below 3%, making the delivered dose knowable rather than estimated.

  • Brands covered by independent testing: Natural Factors, Nature’s Way, NOW, Pure Encapsulations, Swanson, Traditional Medicinals, and Vital Nutrients all appear in published third-party licorice testing; inclusion is not the same as passing, and three deglycyrrhizinated products in that round were not approved.

Practical Considerations

  • Time to effect: Digestive symptom relief appears within 7–14 days and is usually clear by day 30. Blood-pressure and potassium changes emerge over the same window, so benefit and risk arrive together.

  • Common pitfalls: Assuming all licorice products are equivalent. Whole root, deglycyrrhizinated licorice, and flavonoid oil have different mechanisms, different benefits, and one of the three carries nearly all the risk.

  • Second common pitfall: Counting only supplements. Licorice tea, black licorice candy, herbal blends, throat lozenges, and some chewing tobacco all add glycyrrhizin toward the same daily ceiling.

  • Third common pitfall: Continuous use without a break. Because enzyme inhibition persists one to two weeks, daily dosing accumulates an effect that intermittent measurement can easily miss.

  • Regulatory status: Sold as a dietary supplement and food ingredient in the United States, with the Food and Drug Administration issuing consumer advisories rather than restrictions. The European Union recommends a 100 mg daily glycyrrhizin ceiling.

  • Cost and accessibility: Inexpensive and universally available at a few cents per serving. Because the drugs it competes with are also cheap generics, no insurer or health system has a systematic incentive favouring either.

Interaction with Foundational Habits

  • Sleep: Direct and potentially disruptive. By prolonging cortisol’s action, whole-root licorice taken in the afternoon or evening can delay sleep onset and fragment sleep. Morning dosing avoids this; deglycyrrhizinated forms lack the effect and can be taken at any hour.

  • Nutrition: Direct and bidirectional. Licorice depletes potassium and retains sodium, so a high-potassium, lower-sodium pattern blunts both. Leafy greens, avocado, beans, and potatoes replace the potassium lost; processed foods supply the sodium that is then retained, and licorice-containing teas and candies count within the daily glycyrrhizin total.

  • Exercise: Indirect, mostly neutral. Licorice flavonoid oil produced no meaningful change in muscle mass or performance, but hypokalemia caused by whole root increases cramping and rhabdomyolysis risk during heavy training. Potassium status is therefore confirmed before heavy training and whole root are combined.

  • Stress management: Direct and potentiating. Licorice prolongs cortisol’s effect rather than raising its production, so it compounds an already-elevated stress response. Practices that lower physical arousal offset it, and whole root is generally set aside during periods of high sustained stress.

Monitoring Protocol & Defining Success

Before a glycyrrhizin-containing preparation is started, the baseline consists of seated blood pressure averaged over three readings on separate days, a comprehensive metabolic panel covering potassium, sodium, and liver enzymes, plus plasma renin activity and serum aldosterone if any pressure elevation already exists. Body weight and a photograph of the face and ankles give a useful reference for later comparison.

Potassium and blood pressure are rechecked at 2 weeks and 4 weeks, then every 3 months while use continues. With concurrent diuretics, corticosteroids, or antihypertensives the first recheck moves to week 1. Deglycyrrhizinated preparations need no electrolyte schedule; annual routine bloodwork is sufficient. Success is symptom improvement in the targeted domain with potassium, pressure, and weight unchanged from baseline.

Biomarker Optimal Functional Range Why Measure It? Context/Notes
Serum potassium 4.2–4.8 mmol/L The first and most sensitive marker of mineralocorticoid excess Conventional labs flag only below 3.5 mmol/L; drift within the normal range is the early warning. Fist-clenching during the draw falsely raises the result
Blood pressure (home, seated) Below 120/80 mmHg Directly tracks the principal dose-limiting effect Averaged over three morning readings; a rise of 5 mmHg systolic over baseline warrants dose reduction
Plasma renin activity 0.5–2.0 ng/mL/hour Suppression confirms licorice is driving mineralocorticoid activity Drawn seated after 15 minutes’ rest; conventional ranges are wider and miss early suppression. Paired with aldosterone
Serum aldosterone 4–20 ng/dL Falls alongside renin, confirming the mechanism rather than another cause of hypertension Morning draw, seated; interpreted only as the aldosterone-to-renin ratio alongside the renin result
Serum sodium 137–142 mmol/L Rises with sodium retention, often before weight or pressure change Upper-normal drift with concurrent low potassium is characteristic of licorice, not incidental
Serum magnesium (red blood cell) 5.0–6.5 mg/dL Magnesium is lost alongside potassium and its depletion blocks potassium repletion Red-cell magnesium reflects stores far better than the serum test most labs run by default
Alanine aminotransferase 10–26 U/L (women), 10–33 U/L (men) Tracks the hepatic benefit claimed for licorice in liver disease Conventional upper limits reach 40–55 U/L, well above the functional target. Requires an 8–12 hour fast
Total testosterone 600–900 ng/dL (men), 15–45 ng/dL (women) Detects the androgen-lowering effect, unwanted in men and intended in women Drawn between 7 and 10 a.m. when levels peak; paired with sex hormone binding globulin
Morning salivary cortisol 0.10–0.30 µg/dL at waking Shows whether cortisol exposure is being extended as intended Collected within 30 minutes of waking, before food or brushing teeth; a four-point curve is more informative than a single sample
Body weight No established target; track change from the individual’s own baseline A 1–2 kg gain without diet change is the earliest sign of fluid retention Weighed on waking, after voiding, before eating, on the same scale each time

Alongside the laboratory picture, the qualitative markers tracked are:

  • Facial, hand, and ankle puffiness, compared against the baseline photograph
  • Muscle cramps, twitching, or unusual weakness climbing stairs
  • Morning energy and the time of day at which alertness fades
  • Sleep onset latency and night waking, particularly after any evening dose
  • Heartburn, regurgitation, and post-meal fullness, if that was the target
  • Headache, particularly a new pattern of morning headache

Emerging Research

  • Glycyrrhizin in prostate cancer: NCT06378346, a Phase 2 window-of-opportunity study in 60 men, measuring change in prostate-specific antigen (a blood marker of prostate activity) after glycyrrhizin and before surgery. Sponsored by the University of Illinois at Chicago.

  • Licorice in metabolic-associated fatty liver disease: NCT06798948, a Phase 2 randomised trial in 100 patients combining Glycyrrhiza glabra with artichoke, milk thistle, and turmeric, with liver fat measured by magnetic resonance imaging.

  • Licorice as an adjunct in Helicobacter pylori eradication: NCT06881524, a 374-participant trial pairing low-dose amoxicillin dual therapy with licorice and lotus root powder, with eradication rate as the primary endpoint.

  • Glycyrrhizinate as a steroid add-on in immune thrombocytopenia: NCT05023915, a Phase 2 study of 106 patients adding diammonium glycyrrhizinate to dexamethasone in immune thrombocytopenia (low platelet counts caused by immune attack), testing the anti-inflammatory rather than the mineralocorticoid action.

  • Where the dose ceiling may move downward: af Geijerstam et al., 2024 found blood-pressure and cardiac-strain signals at 100 mg glycyrrhizic acid daily, the intake regulators had assumed safe. Replication in older adults would weaken the case for whole-root use.

  • Where the flavonoid case may strengthen: Wu et al., 2024 showed licorice flavonoids do not raise blood pressure while glycyrrhizic acid does. Trials of flavonoid-only extracts at therapeutic doses would separate benefit from harm decisively.

  • Where the longevity claim will be tested or fail: The senescence and lifespan findings remain confined to cell culture and Caenorhabditis elegans, as in Reigada et al., 2020. No mammalian lifespan study is registered, so the claim stays untestable for now.

  • Where independence is still missing: The dyspepsia and reflux evidence rests on manufacturer-funded trials of a single branded extract — Raveendra et al., 2012 and Raj et al., 2025. An independently funded replication would either confirm the digestive benefit or dissolve it.

Conclusion

Licorice root is two different things sold under one name, and the distinction decides everything. The whole root carries the sweet compound that blocks the enzyme switching off the body’s main stress hormone. That single action explains the traditional uses, the effect on energy, and every serious harm on record: rising blood pressure, potassium loss, swelling, and dangerous heart rhythms. It grows with the dose and begins below what a daily tea habit supplies. Processed forms that strip it out keep the digestive benefit and shed most of the hazard.

The strongest evidence is narrow: relief of indigestion and reflux symptoms, prevention of throat pain after surgery, faster healing of mouth ulcers, better liver readings in people who already have liver disease, and better results in two patchy skin and hair conditions when a licorice-derived prescription form is added to standard care. Effects on weight and sex hormones are real but small. The claims tied to ageing itself rest on cell cultures and worms.

The evidence base has two structural weaknesses. Much of the digestive research was paid for by the company selling the extract, and none of it has been repeated independently. And because licorice competes with cheap generic medicines, no insurer or health system has a stake either way, which leaves the field to commercial sponsors.

For someone already tracking blood pressure and mineral balance, the processed preparations carry a modest, well-defined benefit, while the whole root acts on salt, water, and hormones rather than on ageing.

Top - Benefits - Risks - Protocol